Anistreplase

In the US, Anistreplase is a member of the drug class thrombolytics and is used to treat Heart Attack.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AD03

CAS registry number (Chemical Abstracts Service)

0081669-57-0

Therapeutic Category

Anticoagulant agent: Fibrinolytic

Chemical Name

Plasminogen-Streptokinase-4-Amidinophenyl p-anisat hydrochlorid (1:1:1)

Foreign Names

• Anistreplasum (Latin)
• Anistreplase (German)
• Anistreplase (French)
• Anistreplasa (Spanish)

Generic Names

• Anistreplase (OS: BAN, DCF, USAN)
• APSAC (IS)
• BRL 26921 (IS)

Brand Name

• Eminase
  Pharmateam, Israel

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.